JPS63148982A - Cultivation of insect cell using autoclave-sterilized serum-free culture medium - Google Patents
Cultivation of insect cell using autoclave-sterilized serum-free culture mediumInfo
- Publication number
- JPS63148982A JPS63148982A JP61294941A JP29494186A JPS63148982A JP S63148982 A JPS63148982 A JP S63148982A JP 61294941 A JP61294941 A JP 61294941A JP 29494186 A JP29494186 A JP 29494186A JP S63148982 A JPS63148982 A JP S63148982A
- Authority
- JP
- Japan
- Prior art keywords
- culture medium
- serum
- cells
- medium
- autoclave
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000238631 Hexapoda Species 0.000 title claims abstract description 24
- 239000004017 serum-free culture medium Substances 0.000 title description 4
- 238000000034 method Methods 0.000 claims abstract description 27
- 230000001954 sterilising effect Effects 0.000 claims abstract description 27
- 239000001963 growth medium Substances 0.000 claims abstract description 16
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims abstract description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 12
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 10
- 108010088751 Albumins Proteins 0.000 claims abstract description 7
- 102000009027 Albumins Human genes 0.000 claims abstract description 7
- 239000001103 potassium chloride Substances 0.000 claims abstract description 6
- 235000011164 potassium chloride Nutrition 0.000 claims abstract description 6
- 239000011780 sodium chloride Substances 0.000 claims abstract description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 22
- 239000012679 serum free medium Substances 0.000 claims description 15
- 238000012258 culturing Methods 0.000 claims description 13
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 10
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 239000001110 calcium chloride Substances 0.000 claims description 6
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 6
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 6
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 5
- 235000002639 sodium chloride Nutrition 0.000 claims description 5
- 235000000346 sugar Nutrition 0.000 claims description 4
- 235000011148 calcium chloride Nutrition 0.000 claims description 3
- 235000011147 magnesium chloride Nutrition 0.000 claims description 3
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 3
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 3
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 3
- 150000008163 sugars Chemical class 0.000 claims description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims 1
- 210000002966 serum Anatomy 0.000 abstract description 16
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract description 8
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 abstract description 5
- 229940052299 calcium chloride dihydrate Drugs 0.000 abstract description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 4
- 229940050906 magnesium chloride hexahydrate Drugs 0.000 abstract description 4
- DHRRIBDTHFBPNG-UHFFFAOYSA-L magnesium dichloride hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[Cl-].[Cl-] DHRRIBDTHFBPNG-UHFFFAOYSA-L 0.000 abstract description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 abstract description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 abstract description 4
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 abstract description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 abstract description 2
- 235000019800 disodium phosphate Nutrition 0.000 abstract description 2
- 239000001488 sodium phosphate Substances 0.000 abstract description 2
- 241000555303 Mamestra brassicae Species 0.000 abstract 2
- 235000013312 flour Nutrition 0.000 abstract 1
- 230000000644 propagated effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 55
- 239000002609 medium Substances 0.000 description 22
- 239000000306 component Substances 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 229960002713 calcium chloride Drugs 0.000 description 5
- 238000004113 cell culture Methods 0.000 description 5
- 229960002337 magnesium chloride Drugs 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 108090000942 Lactalbumin Proteins 0.000 description 4
- 102000004407 Lactalbumin Human genes 0.000 description 4
- 241000256248 Spodoptera Species 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- -1 that is Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 241001477931 Mythimna unipuncta Species 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 239000006143 cell culture medium Substances 0.000 description 2
- RCJVRSBWZCNNQT-UHFFFAOYSA-N dichloridooxygen Chemical compound ClOCl RCJVRSBWZCNNQT-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000003677 hemocyte Anatomy 0.000 description 2
- 229940000351 hemocyte Drugs 0.000 description 2
- 239000012533 medium component Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- WMFHUUKYIUOHRA-UHFFFAOYSA-N (3-phenoxyphenyl)methanamine;hydrochloride Chemical compound Cl.NCC1=CC=CC(OC=2C=CC=CC=2)=C1 WMFHUUKYIUOHRA-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- YMIFCOGYMQTQBP-UHFFFAOYSA-L calcium;dichloride;hydrate Chemical compound O.[Cl-].[Cl-].[Ca+2] YMIFCOGYMQTQBP-UHFFFAOYSA-L 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- MJMDTFNVECGTEM-UHFFFAOYSA-L magnesium dichloride monohydrate Chemical compound O.[Mg+2].[Cl-].[Cl-] MJMDTFNVECGTEM-UHFFFAOYSA-L 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000011177 media preparation Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- BBMHARZCALWXSL-UHFFFAOYSA-M sodium dihydrogenphosphate monohydrate Chemical compound O.[Na+].OP(O)([O-])=O BBMHARZCALWXSL-UHFFFAOYSA-M 0.000 description 1
- OTNVGWMVOULBFZ-UHFFFAOYSA-N sodium;hydrochloride Chemical compound [Na].Cl OTNVGWMVOULBFZ-UHFFFAOYSA-N 0.000 description 1
- 238000011146 sterile filtration Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、昆虫細胞、特にヨトウガ由来細胞を培養する
ための湿熱滅菌法、好ましくはオートクレーブ加熱法で
滅菌した無血清の昆虫細胞培養培地を用いて昆虫細胞を
培養する技術に関する。[Detailed Description of the Invention] [Industrial Application Field] The present invention provides a serum-free insect cell culture medium sterilized by a moist heat sterilization method, preferably an autoclave heating method, for culturing insect cells, particularly cells derived from armyworm moth. The present invention relates to a technique for culturing insect cells using the present invention.
(従来の技術〕
昆虫細胞を用いて、昆虫ウィルスを生産すること、並び
にヒトインターフェロンの生産等の、動物細胞で生産す
る有用物質を免疫的に無関係の昆虫細胞を用いて生産す
ることが研究されている。(Prior Art) Research has been conducted on the production of insect viruses using insect cells, as well as the production of useful substances produced in animal cells, such as the production of human interferon, using immunologically unrelated insect cells. ing.
一般に、昆虫細胞の培養に当っては、子牛おるいは牛胎
児等より得られる血清を培地成分として使用している。Generally, when culturing insect cells, serum obtained from calves or bovine fetuses is used as a medium component.
ところが、この血清は高価であるのみならず、品質の不
均一性、不安定性、大量入手の困難さから、血清を含有
しないでも昆虫細胞を培養できる培地の研究がなされて
いる。その結果、いくつかの無血清培地が開発された。However, this serum is not only expensive, but also has uneven quality, instability, and is difficult to obtain in large quantities. Therefore, research is being conducted on a medium that can culture insect cells without containing serum. As a result, several serum-free media have been developed.
例えば、ショウジヨウバエ細胞用の培地(ジーエカリア
ニイー、カースタック、ケー、マラモロシュ編「インバ
ーチプレイド・ティッシュウ・カルチャー・アプリケイ
ジョン・イン・メディシン・バイオロジー・アンド・ア
プリカルチャーJ (Invertabra−te
Ti5st+e Cu1ture 、Applica
tions in Medicine。For example, media for Drosophila cells (G.E.Kalianii, Karstack, K., Maramoros, eds., "Inverted Tissue Culture Applications in Medicine Biology and Applications J. -te
Ti5st+e Culture, Applica
tions in Medicine.
Biology and Agriculture、)
131−150頁、アカデミツク・プレス社 ニュー
ヨーク 1976年発行:ケイ、ディ、ディビス、ニー
、シャーン:「サイエンスJ (Science)
196巻438−440頁、1977年〕、力細胞用の
培地〔ニス、キタムラ等「ジャーナル・メディカル−I
ントモロジーj (J、Hed、Entom−01,)
10巻488−489頁、1973年〕、りんし目、双
し目昆虫細胞の培地としてミツハシ、マラモロシュ(M
itsuhashi and Maramorosch
)培地〔ジエイ、ミツハシ、ケイ、マラモロシュ「コン
トリビュート・ボイス・トンプソン・インステイチュー
トJ(Contrib、Boyce Thompso
n In5t、)22巻 435−460頁、196
4年〕より、血清を取除いた組成の培地等が使用されて
いる。Biology and Agriculture,)
pp. 131-150, Academic Press, New York, 1976. K., D., Davis, N., Shaan: Science J.
196, pp. 438-440, 1977], medium for force cells [Niss, Kitamura et al., “Journal Medical-I
Entomology j (J, Hed, Entom-01,)
10, pp. 488-489, 1973], Mitsuhashi and Maramoros (M.
Itsuhashi and Maramorosch
) Medium [J.E., Mitsuhashi, K., Maramolos, Contribute to Boyce Thompson Institute J (Contrib, Boyce Thompson
n In5t, ) Vol. 22, pp. 435-460, 196
Since [2004], a culture medium with a serum-free composition has been used.
これらの無血清培地の滅菌処理方法としては、濾過滅菌
が行われている。その方法は、滅菌したメンブレン・フ
ィルターを用いるのが通常である。Filtration sterilization is used as a method for sterilizing these serum-free media. The method typically uses sterile membrane filters.
培地調製後、直接に除菌用のフィルターに通すと、目づ
まりが著しく、効率的でない。したがって、前処理とし
て、調製直後の培地から高速遠心分離機で沈澱物を除去
し、段階的にポアサイズの異なるフィルターで濾過する
が、フィルター交換、各操作中での容器の準備等の操作
が繁雑である。また、濾過滅菌後の培地を各々の培養器
へ移す分注作業を無菌状態で行なう必要が必り、無菌操
作技術の熟練修得者が作業する必要がおる。特に大量の
培地の分注を、雑菌の混入なしに行なうことは高度の無
菌操作技術が必要とされる。大量培養にiJ′−3いて
は専用の無菌濾過装置を必要とし、設備投資および維持
管理費が大きくなる。If you pass the culture medium directly through a sterilization filter after preparing it, it will become extremely clogged and inefficient. Therefore, as a pretreatment, the precipitate is removed from the culture medium immediately after preparation using a high-speed centrifuge, and the precipitate is filtered step by step through filters with different pore sizes, but operations such as filter replacement and container preparation during each operation are complicated. It is. Furthermore, the dispensing operation of transferring the filter-sterilized culture medium to each incubator must be performed under aseptic conditions, and the operation must be carried out by a person skilled in aseptic operation techniques. In particular, dispensing a large amount of culture medium without contaminating bacteria requires a high degree of aseptic technique. For mass culture, iJ'-3 requires a dedicated sterile filtration device, which increases equipment investment and maintenance costs.
このような事情から、高度の無菌操作を必要とせず、特
定の技術修得者に限らず誰でも簡単な操作で調製できる
安価な培地を開発することが要望されている。本発明は
、このような要望に合致した昆虫細胞培養用の無血清培
地を用いる昆虫細胞の無血清培養法を提供することを目
的とする。Under these circumstances, there is a demand for the development of an inexpensive culture medium that does not require a high degree of sterile operation and can be prepared by anyone, not just those with specific technical skills, with simple operations. An object of the present invention is to provide a serum-free culture method for insect cells using a serum-free medium for culturing insect cells that meets such demands.
C問題点を解決するための手段)
本発明者らは、このような事情にもとすき、かかる問題
点を解決すべく研究を行い、これまでのミツハシ、マラ
モロシュ(Hitsuhashi and Haram
−orosch)培地より血清をとりのぞいた培地をオ
ートクレーブ滅菌により無菌状態とし、この培地で昆虫
細胞を培養することが可能であることを認め、本発明に
いたった。すなわち、従来用いられていた昆虫細胞培養
用培地に代り、酵母粉末とアルブミン加水分解物(水解
物)を配合し、かっ血清成分を含まない培地は、熱処理
を行なうことによっても昆虫細胞の培養に必要な成分を
失うことなく、十分に昆虫細胞の増殖を行なわしめるこ
とを知見した。Means for Solving Problem C) In view of the above circumstances, the present inventors conducted research to solve the problem, and the present inventors conducted research to solve the problem, and the present inventors conducted research to solve the problem.
The present invention was based on the recognition that it is possible to culture insect cells in a medium obtained by removing serum from a medium (from which the serum has been removed) by sterilizing it in an autoclave. In other words, instead of the conventionally used insect cell culture medium, a medium containing yeast powder and albumin hydrolyzate (hydrolyzate) and containing no serum components can be used for culturing insect cells by heat treatment. It was discovered that insect cells can be sufficiently grown without losing necessary components.
従って、本発明によると、塩化ナトリウム、塩化カリウ
ム、リン酸二水素ナトリウム、#酸水素ナトリウム、塩
化マグネシウム、塩化カルシウム、糖類、酵母粉末およ
びアルブミン水解物を含有し、実質的に血清を含まない
培地を湿熱滅菌法により無菌状態とした培地で、昆虫細
胞を培養する方法が提供される。According to the invention, therefore, a substantially serum-free medium containing sodium chloride, potassium chloride, sodium dihydrogen phosphate, sodium hydrogen chloride, magnesium chloride, calcium chloride, sugars, yeast powder and albumin hydrolyzate, Provided is a method for culturing insect cells in a medium made sterile by moist heat sterilization.
本発明の方法で用いる培地は、ミツハシ・マラモロシュ
(Mitsuhashi and )laramoro
sch)培地より血清をとりのぞいた残余の成分、すな
わち塩化ナトリウム、塩化カリウム、リン酸二水素ナト
リウム、炭酸水素ナトリウム、塩化マグネシウム、塩化
カルシウム、糖類に酵母粉末およびアルブミン水解物を
加えて成る組成の培地を用い、従来の培地と同様に、i
)H値を、水酸化カリウム、塩酸等を用いて5,6〜7
.0の範囲に調製したのら、湿熱滅菌することによって
無菌の無血清培地として調製できる。The medium used in the method of the present invention is Mitsuhashi and Maramoro
sch) A composition made by adding yeast powder and albumin hydrolyzate to the remaining components after removing serum from the medium, that is, sodium chloride, potassium chloride, sodium dihydrogen phosphate, sodium hydrogen carbonate, magnesium chloride, calcium chloride, and sugars. Using the medium, i
)H value to 5,6-7 using potassium hydroxide, hydrochloric acid, etc.
.. Once adjusted to a range of 0, a sterile serum-free medium can be prepared by sterilizing with moist heat.
上記の成分のうち、塩化マグネシウムとしては、塩化マ
グネシウム無水物、塩化マグネシウム六水和物が使用で
きるが、塩化マグネシウム六水和物が好ましい。また塩
化カルシウムとしては、塩化カルシウム無水物、塩化カ
ルシウム二水和物、塩化カルシウム穴水和物が使用でき
るが、塩化カルシウムニ水和物が好ましい。Among the above components, as magnesium chloride, magnesium chloride anhydride and magnesium chloride hexahydrate can be used, but magnesium chloride hexahydrate is preferable. Further, as calcium chloride, calcium chloride anhydrate, calcium chloride dihydrate, and calcium chloride hydrate can be used, but calcium chloride dihydrate is preferable.
また、糖類としては、D−グルコース、フラクトースが
使用できるが、D−グルコースが好ましい。また、酵母
粉末としてはパン酵母粉末、ビール酵母粉末が使用でき
るが、パン酵母粉末が好ましい。またアルブミン水解物
としては、血清アルブミン水解物、ラクトアルブミン水
解物、卵白アルブミン水解物が使用できるが、ラクトア
ルブミン水解物が好ましい。Further, as the sugar, D-glucose and fructose can be used, but D-glucose is preferable. Further, as the yeast powder, baker's yeast powder and brewer's yeast powder can be used, but baker's yeast powder is preferable. As the albumin hydrolyzate, serum albumin hydrolyzate, lactalbumin hydrolyzate, and egg albumin hydrolyzate can be used, but lactalbumin hydrolyzate is preferable.
湿熱滅菌法としては、オートクレーブ滅菌法、間欠加熱
法が使用できるが、オートクレーブ滅菌法が好ましい。As the moist heat sterilization method, an autoclave sterilization method and an intermittent heating method can be used, but the autoclave sterilization method is preferable.
ざらには、滅菌操作の前、もしくは後の上記培地成分に
血清を加えることもできる。Alternatively, serum can be added to the above medium components before or after sterilization.
本発明の方法で使用される昆虫細胞培養用の無血清培地
の各成分は、いずれも市販品をそのまま使用できるから
、安価に安定して入手が可能であり、ざらに、高度な技
術の濾過滅菌操作にようないで、簡単なオートクレーブ
でスチーム滅菌法により目的を達成することができるの
で、無菌操作についての技術修得者でない誰でもが調製
できる。Each component of the serum-free medium for insect cell culture used in the method of the present invention can be used as commercially available products, so it can be obtained stably at low cost. Since the purpose can be achieved by steam sterilization using a simple autoclave without any sterilization, anyone who is not an expert in aseptic techniques can prepare the product.
本発明の方法で使用される無血清培地を調製するには、
これまでの昆虫細胞用無血清培地の常用成分として知ら
れている次の無機塩成分、すなわち、塩化ナトリウム(
6,0〜8.0’ii/Q、培地1Q当りの好適な添加
最:以下同じ)、塩化カリウム(0,1〜0.3g/Q
>、リン酸二ナトリウム(0,1〜0.4p/り)、炭
酸水素ナトリウム(0,1〜0,47/2)、塩化マグ
ネシウム六水和物(0,05〜0.2g/Q)及び塩化
カルシウムニ水和物(0,1〜0.3y#2)、並びに
D−グルコース(2,0〜8.09/Q)と、これらに
アルブミン水解物(3,O〜15.09/Q>及び酵母
粉末(1,0〜8.09/Q>を加えて成る組成の培地
を調製する。その後、pHを水酸化カリウム、塩酸等を
用いてpti5.6〜7.0の範囲に調整すればよい。To prepare the serum-free medium used in the method of the invention,
The following inorganic salt components are known as common components of serum-free media for insect cells, namely, sodium chloride (
6.0-8.0'ii/Q, suitable addition maximum per 1Q of medium: the same applies below), potassium chloride (0.1-0.3g/Q
>, disodium phosphate (0.1-0.4 p/litre), sodium hydrogen carbonate (0.1-0.47/2), magnesium chloride hexahydrate (0.05-0.2 g/Q) and calcium chloride dihydrate (0,1~0.3y#2), and D-glucose (2,0~8.09/Q), and albumin hydrolyzate (3,0~15.09/Q) to these. Prepare a medium with a composition by adding Q> and yeast powder (1.0 to 8.09/Q>. Then, adjust the pH to a pti range of 5.6 to 7.0 using potassium hydroxide, hydrochloric acid, etc. Just adjust it.
これらの培地成分は、いずれも市販品をそのまま使用す
ればよい。Commercially available products may be used as they are for these culture medium components.
また、これ以外の成分、すなわち塩化マグネシウム無水
物、塩化カルシウム無水物、塩化カルシウム二水和物、
等も同様に使用することができる。In addition, other ingredients, namely magnesium chloride anhydride, calcium chloride anhydride, calcium chloride dihydrate,
etc. can be used similarly.
また、湿熱滅菌法として、オートクレーブ滅菌する方法
は、通常の方法、すなわち、1.0〜1.2気圧のスチ
ーム雰囲気下に、15〜30分間、110〜130℃で
加熱することから成る。このようにして、本発明で用い
る無菌状態の無血清培地を調製できる。Further, as a moist heat sterilization method, autoclave sterilization is a conventional method, that is, heating at 110 to 130° C. for 15 to 30 minutes in a steam atmosphere of 1.0 to 1.2 atmospheres. In this way, a sterile serum-free medium used in the present invention can be prepared.
以下に実施例を挙げて本発明を詳述するが、これらは単
なる例示であって、本発明を制限するものではない。The present invention will be described in detail below with reference to Examples, but these are merely illustrative and do not limit the present invention.
実施例 1
後記の表1の組成で各成分を含む無血清培地を調製し、
オートクレーブで加熱(120’Cl2O分)、滅菌し
た無菌培地の5dを、コーニング社製プラスチック・フ
ラスコ(25cm)に分注した。Example 1 A serum-free medium containing each component with the composition shown in Table 1 below was prepared,
5 d of sterile medium heated in an autoclave (120' Cl2O min) and sterilized was dispensed into Corning plastic flasks (25 cm).
他方、あらかじめ、オートクレーブ滅菌した表1の培地
で4日間培養して得たヨトウガ脂肪体由来細胞の4種、
5ES−HaBr−1; 5ES−HaBr−2; 5
ES−)faBr−3; 5ES−HaBr−4と血球
由来細胞の2種NIAS−)1aBr−92; NIA
S−HaBr−93と、卵巣由来細胞の1種NIAS−
MaBr−32とを、それぞれ初発細胞濃度が2.0x
105個/m!!になるように接種した。On the other hand, four types of Spodoptera fat pad-derived cells obtained by culturing for 4 days in the medium shown in Table 1, which had been sterilized in an autoclave in advance,
5ES-HaBr-1; 5ES-HaBr-2; 5
ES-) faBr-3; 5ES-HaBr-4 and two types of blood cell-derived cells NIAS-) 1aBr-92; NIA
S-HaBr-93 and NIAS-, a type of ovary-derived cell
and MaBr-32 at an initial cell concentration of 2.0x.
105 pieces/m! ! It was inoculated so that
これらのフラスコを25℃に保温された細胞培養器の中
に静置して培養したところ、9日間の後の細胞数は、そ
れぞれ21.8x 10”個/rrd! : 18.1
X10 個/lrd! ; 21.7x 105個/
7: 16.4X10 個/ml+ 11.9X
’l o5個/d: 1B、5x10 個: 18
.3X 105個/mlまでに増加した。When these flasks were placed and cultured in a cell incubator kept at 25°C, the number of cells after 9 days was 21.8 x 10" cells/rrd!: 18.1.
X10 pieces/lrd! ; 21.7x 105 pieces/
7: 16.4X10 pieces/ml+11.9X
'l o5 pieces/d: 1B, 5x10 pieces: 18
.. It increased to 3X 105 cells/ml.
表 1
塩化ナトリウム 7゜Oc+/Qリ
ン酸二水素ナトリウム−水和物 0.2 9IQ炭酸水
素ナトリウム 0.12q/Q塩化カリウ
ム 0.2 gIQ塩化塩化マ
グネシウム和水和物 0.1 a/Q塩化塩化カル
シウム和水和物 0.2 g/QD−グルコース
4.Og、1ラクトアルブミン水
解物 6.5g/Qイーストレイト
5.Oa!Q(ディフコ DifCO製)
pH6,5±0.2
なあ、上記の表中のラクトアルブミン水解物は、ニュー
トリショナル・バイオケミカルズ・コーポレーション(
Nutiritional Biochemicals
Corp、)製でおる。Table 1 Sodium chloride 7°Oc+/Q Sodium dihydrogen phosphate hydrate 0.2 9IQ Sodium hydrogen carbonate 0.12q/Q Potassium chloride 0.2 gIQ chloride Magnesium chloride hydrate 0.1 a/Q chloride Calcium chloride hydrate 0.2 g/QD-glucose 4. Og, 1 Lactalbumin Hydrolyzate 6.5g/Q Yeastrate
5. Oa! Q (manufactured by Difco) pH 6.5 ± 0.2 By the way, the lactalbumin hydrolyzate in the above table is manufactured by Nutritional Biochemicals Corporation (
Nutritional Biochemicals
Corp.).
叉思f41 2
表1に示した組成の無血清培地を調製し、実施例1で用
いた滅菌法により滅菌した後、牛脂児血清(ディフコ
Difco製〉を血清濃度3%になるように無菌的に添
加して血清含有培地を調製した。After preparing a serum-free medium with the composition shown in Table 1 and sterilizing it using the sterilization method used in Example 1, add beef tallow serum (Difco
(manufactured by Difco) was added aseptically to give a serum concentration of 3% to prepare a serum-containing medium.
この血清含有培地の5mlを、コーニング社製プラスチ
ック・フラスコ(25cIA)に分注した。他方、あら
かじめ、上記血清含有培地で4日間培養して得たヨトウ
ガ血球由来細胞NIAS−HaBr−93を、初発細胞
濃度が、2.OX 105個/dになるように接種した
。5 ml of this serum-containing medium was dispensed into a Corning plastic flask (25cIA). On the other hand, armyworm hemocyte-derived cells NIAS-HaBr-93, which had been previously cultured in the serum-containing medium for 4 days, were incubated at an initial cell concentration of 2. It was inoculated at 105 OX/d.
このフラスコを25℃に保温された細胞培養器の中に静
置して培養したところ、9日間の後の細胞数は18.2
X 10”個/dまでに増加した。When this flask was placed in a cell culture vessel kept at 25°C and cultured, the number of cells after 9 days was 18.2.
It increased to X 10” pieces/d.
実施例 3
表1に示した組成の無血清培地を調製し、実施例1で用
いた滅菌法により滅菌し、内容1250m1のガラス製
スピンナーかくはん培養器に、10(Mづつ分注した。Example 3 A serum-free medium having the composition shown in Table 1 was prepared, sterilized by the sterilization method used in Example 1, and dispensed in 10 (M) portions into glass spinner-stirred culture vessels with a capacity of 1250 ml.
あらかじめ、オートクレーブ滅菌した表1の培地で4日
間培養して得たヨトウガ血球由来細胞N IAS−)1
aBr−93を、初発細胞濃度が2.OX 105個/
dになるように接種した。Spodoptera hemocyte-derived cells N IAS-)1 obtained by culturing for 4 days in the medium shown in Table 1, which had been sterilized in an autoclave in advance.
aBr-93 at an initial cell concentration of 2. OX 105 pieces/
It was inoculated so that it became d.
25℃に保温された細胞培#L器の中で、かくはん数、
毎分60回でかくはんし、10日間培養した。培養後の
細胞数は、9.07 X 105個/dまで増加し、1
本のスピンナー培養器から9.07X107個の細胞が
無血清培養により取得された。In a cell culture #L vessel kept at 25°C, stir the
The mixture was stirred at 60 times per minute and cultured for 10 days. The number of cells after culture increased to 9.07 x 105 cells/d, and 1
9.07×10 7 cells were obtained by serum-free culture from a book spinner incubator.
叉塵叢−1
表1に示した組成の無血清培地を調製し、実施例1で用
いた滅菌法により滅菌し、内容量250威のガラス製ス
ピンナーかくはん培養器に、100dづつ分注した。あ
らかじめ、オートクレーブ滅菌した表1の培地で4日間
培養して得たヨトウガ脂肪体由来細胞5ES−)1aB
r−1を、初発細胞濃度が2.Ox 10”個/dにな
るように接種した。Chimney dust colony-1 A serum-free medium having the composition shown in Table 1 was prepared, sterilized by the sterilization method used in Example 1, and dispensed in 100 ml portions into a glass spinner-stirred culture vessel with an internal capacity of 250 liters. Spodoptera fat pad-derived cells 5ES-) 1aB obtained by culturing for 4 days in the medium shown in Table 1 which had been sterilized in an autoclave in advance
r-1 with an initial cell concentration of 2. The seedlings were inoculated at 10" Ox/d.
25℃に保温された細胞培養器の中で、かくはん数、毎
分60回でかくはんし、10日間培養した。培養後の細
胞数は、10.8X 10”個/dまで増加し、1本の
スピンナー培養器から1.08X108個の細胞が無血
清培養により取得された。The cells were stirred at a rate of 60 times per minute in a cell culture vessel kept at 25° C. and cultured for 10 days. The number of cells after culturing increased to 10.8 x 10'' cells/d, and 1.08 x 108 cells were obtained from one spinner incubator by serum-free culture.
大思輿−二
表1に示した組成の無血清培地を調製し、実施例1で用
いた滅菌法により滅菌し、内容量1.3Qのガラス製ス
ピンナーかくはん培養器に、500d分注づつした。あ
らかじめ、オートクレーブ滅菌した表1の培地で4日間
培養して得たヨトウガ由来細胞N IAS−MaBr−
93を、初発細胞濃度が1.0×10”個/mlG、:
なるように接種した。25°Cに保温された細胞培養器
の中で、かくはん数、毎分40回でかくはんし、12日
間培養した。培養後の細胞数は、8.87 X 1Q5
個/dまで増加し、1本のスピンナー培養器から4.4
4 X ’l Q8個の細胞が無血清培養により取得さ
れた。Daishikoshi-2 A serum-free medium with the composition shown in Table 1 was prepared, sterilized by the sterilization method used in Example 1, and poured into a glass spinner-stirred culture vessel with an internal capacity of 1.3Q in 500d portions. . Spodoptera-derived cells NIAS-MaBr- obtained by culturing for 4 days in the medium shown in Table 1, which had been sterilized in an autoclave in advance.
93, with an initial cell concentration of 1.0 x 10" cells/mlG:
I was vaccinated accordingly. The cells were stirred at 40 times per minute and cultured for 12 days in a cell culture vessel kept at 25°C. The number of cells after culture is 8.87 x 1Q5
4.4 cells/d from one spinner incubator.
4×'lQ8 cells were obtained by serum-free culture.
実施例 6
表1に示した組成の無血清培地を調製し、実施例1で用
いた滅菌法により滅菌し、内容ff15Qのガラス製ミ
ニジャー培養器に、3Q分づつ注した。Example 6 A serum-free medium having the composition shown in Table 1 was prepared, sterilized by the sterilization method used in Example 1, and poured in 3Q portions into glass mini-jar culture vessels with a content of ff15Q.
必らかしめ、オートクレーブ滅菌した表1の培地で4日
間培養して得たヨトウガ由来細胞NIAS−HaBr−
93を、初発細胞濃度が1.0X10”個/dになるよ
うに接種した。25°Cに保温して、かくはん数、毎分
150回でかくはんし、16日間培養した。培養後の細
胞数は、3.83 X 105個/dまで増加し、1基
のミニジャー培養器から1.15 Xi 09個の細胞
が無血清培養により取得された。Armworm-derived cells NIAS-HaBr- obtained by culturing for 4 days in the medium shown in Table 1, which was sterilized by caulking and autoclaved.
93 was inoculated so that the initial cell concentration was 1.0 x 10'' cells/d.The cells were kept at 25°C, stirred at a rate of 150 times per minute, and cultured for 16 days.Number of cells after culture increased to 3.83 X 10 cells/d, and 1.15 X 09 cells were obtained from one mini-jar incubator by serum-free culture.
本発明によれば、次のような作用効果がもたらされる。 According to the present invention, the following effects are brought about.
まず第1に、培地の無菌処理方法として、これまでの濾
過滅菌によらないで湿熱滅菌法、例えばオートクレーブ
滅菌が可能となった。したがって、濾過殺菌法の高度な
無菌操作を必要とせず、大向培養においても専用の濾過
装置を必要としない。First, as a method for aseptically treating a culture medium, it has become possible to use moist heat sterilization, such as autoclave sterilization, instead of the conventional filtration sterilization. Therefore, the highly aseptic operation of the filtration sterilization method is not required, and the Ohmukai culture also does not require a dedicated filtration device.
その結果、本発明では、特定の技術修得者に限らず誰で
も簡単な操作でかつ安価に調製される無菌の無血清培地
で昆虫細胞の培養をすることができる。As a result, according to the present invention, insect cells can be cultured in a sterile, serum-free medium that is prepared easily and inexpensively by anyone, not only those with specific technical skills.
第2に、本発明の方法で使用する培地の成分は高価な血
清を用いる従来の培地と比べると、すべて市販品で入手
が容易で安価な原料を用いればよく、培地調製が楊めて
容易である。Second, compared to conventional media that use expensive serum, the components of the medium used in the method of the present invention are all commercially available, easily available, and inexpensive raw materials that can be used, making the medium preparation much easier. It is.
第3に、本発明で使用する無血清培地によれば、昆虫細
胞の増殖を、昆虫細胞の種類によって多少の違いがある
が、当初の接種濃度の約3.8〜11倍にも進めること
ができる。このことは実施例1〜実施例6に示したとお
りである。Thirdly, according to the serum-free medium used in the present invention, the proliferation of insect cells can be promoted to approximately 3.8 to 11 times the initial inoculation concentration, although there are some differences depending on the type of insect cells. I can do it. This is as shown in Examples 1 to 6.
Claims (1)
ム、炭酸水素ナトリウム、塩化マグネシウム、塩化カル
シウム、糖類、酵母粉末およびアルブミン水解物を含有
し、実質的に血清を含まない培地を湿熱滅菌法により無
菌状態とした培地で、昆虫細胞を培養する方法。A substantially serum-free medium containing sodium chloride, potassium chloride, sodium dihydrogen phosphate, sodium bicarbonate, magnesium chloride, calcium chloride, sugars, yeast powder, and albumin hydrolyzate was sterilized by moist heat sterilization. A method of culturing insect cells in a culture medium.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61294941A JPH067791B2 (en) | 1986-12-12 | 1986-12-12 | Method for culturing insect cells in autoclave sterilized serum-free medium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61294941A JPH067791B2 (en) | 1986-12-12 | 1986-12-12 | Method for culturing insect cells in autoclave sterilized serum-free medium |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63148982A true JPS63148982A (en) | 1988-06-21 |
JPH067791B2 JPH067791B2 (en) | 1994-02-02 |
Family
ID=17814257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61294941A Expired - Lifetime JPH067791B2 (en) | 1986-12-12 | 1986-12-12 | Method for culturing insect cells in autoclave sterilized serum-free medium |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH067791B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7572632B2 (en) | 1997-02-14 | 2009-08-11 | Life Technologies Corporation | Dry powder cells and cell culture reagents and methods of production thereof |
EP2970916B1 (en) | 2013-03-13 | 2021-04-14 | Merck Sharp & Dohme Corp. | Adapted lepidopteran insect cells for the production of recombinant proteins |
-
1986
- 1986-12-12 JP JP61294941A patent/JPH067791B2/en not_active Expired - Lifetime
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7572632B2 (en) | 1997-02-14 | 2009-08-11 | Life Technologies Corporation | Dry powder cells and cell culture reagents and methods of production thereof |
JP2010233580A (en) * | 1997-02-14 | 2010-10-21 | Life Technologies Corp | Dry powder cell, cell culture reagent and method of production thereof |
JP2014054267A (en) * | 1997-02-14 | 2014-03-27 | Life Technologies Corp | Dry powder cell, cell-culturing reagent, and method for producing them |
JP2016152821A (en) * | 1997-02-14 | 2016-08-25 | ライフ テクノロジーズ コーポレーション | Dry powder cells and cell culture reagents and methods of production thereof |
EP2970916B1 (en) | 2013-03-13 | 2021-04-14 | Merck Sharp & Dohme Corp. | Adapted lepidopteran insect cells for the production of recombinant proteins |
Also Published As
Publication number | Publication date |
---|---|
JPH067791B2 (en) | 1994-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7060494B2 (en) | Growth of human Mesenchymal Stem Cells (hMSC) using umbilical cord blood serum and the method for the preparation thereof | |
Evans et al. | Chemically defined media for cultivation of long-term cell strains from four mammalian species | |
US9957485B2 (en) | Systems and methods for virus propagation in cell cultures for vaccine manufacture | |
CN100389193C (en) | Method for safe continuous enclosed cell culture, virus production/ inactivation | |
CN103409368A (en) | A method for purifying cardiomyocytes or programmed cardiomyocytes derived from stem cells or fetuses | |
Cohen et al. | A simplified chemostat for the growth of mammalian cells: characteristics of cell growth in continuous culture | |
NO823573L (en) | Tissue culture medium. | |
CN114276981B (en) | Vero-E6 suspension cell strain sVero-E6 suitable for porcine epidemic diarrhea virus and application thereof | |
Ziegler et al. | The propagation of mammalian cells in a 20-liter stainless steel fermentor | |
CN103160458A (en) | Low-serum medium suitable for growth of Vero cells | |
US4169761A (en) | Process for the cultivation of viruses | |
CN102604891A (en) | High-amplification multifunctional serum-free medium for immunocyte treatment and preparation method thereof | |
Goldberg et al. | Susceptibility of differentiating muscle cells of the fetal mouse in culture to coxsackievirus A13 | |
JPS63148982A (en) | Cultivation of insect cell using autoclave-sterilized serum-free culture medium | |
CN115261302B (en) | Matrigel and preparation method and application thereof | |
US5468635A (en) | In vitro method for stimulating cell growth by culturing cells in a serum-free culture medium comprising human lysozyme | |
Weiss et al. | Chemically defined serum-free media for the cultivation of primary cells and their susceptibility to viruses | |
CN103484426A (en) | Non-animal source low-protein culture medium | |
Mason | Propagation and growth cycle of Rickettsia quintana in a new liquid medium | |
JPS63148983A (en) | Serum-free culture medium for cultivating insect cell | |
EP0148770B1 (en) | Composition for cell cultivation, production and use thereof | |
Kaplan et al. | A method for preparing smallpox vaccine on a large scale in cultured cells | |
US2990335A (en) | Fluid suspension culture method for fixed tissue cells | |
Shenoy | Animal biotechnology | |
CN110241090B (en) | Method for producing porcine pseudorabies virus antigen by full suspension cell culture |